Patents by Inventor Paul C. Simpson

Paul C. Simpson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SYSTEMS AND METHODS FOR HEALTH DATA VISUALIZATION AND USER SUPPORT TOOLS FOR CONTINUOUS GLUCOSE MONITORING
    Publication number: 20240115211
    Abstract: Disclosed are systems and methods for generating graphical displays of analyte data and/or health information. In some implementations, the graphical displays are generating based on a self-referential dataset that are modifiable based on identified portions of the data. The modified graphical displays can indicate features in the analyte data of a host.
    Type: Application
    Filed: December 19, 2023
    Publication date: April 11, 2024
    Inventors: Esteban CABRERA, JR., Lauren Danielle ARMENTA, Scott M. BELLIVEAU, Jennifer BLACKWELL, Leif N. BOWMAN, Rian DRAEGER, Arturo GARCIA, Timothy Joseph GOLDSMITH, John Michael GRAY, Andrea Jean JACKSON, Apurv Ullas KAMATH, Katherine Yerre KOEHLER, Paul KRAMER, Aditya Sagar MANDAPAKA, Michael Robert MENSINGER, Sumitaka MIKAMI, Gary A. MORRIS, Hemant Mahendra NIRMAL, Paul NOBLE-CAMPBELL, Philip Thomas PUPA, Eli REIHMAN, Peter C. SIMPSON, Brian Christopher SMITH, Atiim Joseph WILEY
  • Transcutaneous analyte sensor
    Patent number: 11937927
    Abstract: A transcutaneous sensor device configured for continuously measuring analyte concentrations in a host is provided. In some embodiments, the transcutaneous sensor device 100 comprises an in vivo portion 160 configured for insertion under the skin 180 of the host and an ex vivo portion 170 configured to remain above the surface of the skin 180 of the host after sensor insertion of the in vivo portion. The in vivo portion may comprise a tissue piercing element 110 configured for piercing the skin 180 of the host and a sensor body 120 comprising a material or support member 130 that provides sufficient column strength to allow the sensor body to be pushable in a host tissue without substantial buckling. The ex vivo portion 170 may be configured to comprise (or operably connect to) a sensor electronics unit and may comprise a mounting unit 150. Also described here are various configurations of the sensor body and the tissue piercing element that may be used to protect the membrane of the sensor body.
    Type: Grant
    Filed: April 23, 2020
    Date of Patent: March 26, 2024
    Assignee: DexCom, Inc.
    Inventors: Peter C. Simpson, Robert J. Boock, Sebastian Bohm, James H. Brauker, Paul V. Neale
  • Systems and methods for health data visualization and user support tools for continuous glucose monitoring
    Patent number: 11931188
    Abstract: Disclosed are systems and methods for generating graphical displays of analyte data and/or health information. In some implementations, the graphical displays are generating based on a self-referential dataset that are modifiable based on identified portions of the data. The modified graphical displays can indicate features in the analyte data of a host.
    Type: Grant
    Filed: September 21, 2021
    Date of Patent: March 19, 2024
    Assignee: Dexcom, Inc.
    Inventors: Esteban Cabrera, Jr., Lauren Danielle Armenta, Scott M. Belliveau, Jennifer Blackwell, Leif N. Bowman, Rian Draeger, Arturo Garcia, Timothy Joseph Goldsmith, John Michael Gray, Andrea Jean Jackson, Apurv Ullas Kamath, Katherine Yerre Koehler, Paul Kramer, Aditya Sagar Mandapaka, Michael Robert Mensinger, Sumitaka Mikami, Gary A Morris, Hemant Mahendra Nirmal, Paul Noble-Campbell, Philip Thomas Pupa, Eli Reihman, Peter C. Simpson, Brian Christopher Smith, Atiim Joseph Wiley
  • Alpha-1-adrenergic receptor agonist therapy
    Patent number: 11213514
    Abstract: Presented herein, inter alia, are novel methods of treating heart diseases.
    Type: Grant
    Filed: February 24, 2017
    Date of Patent: January 4, 2022
    Assignees: The Regents of the University of California, The University of North Carolina at Chapel Hill
    Inventors: Paul C. Simpson, Jr., Brian C. Jensen
  • ALPHA-1-ADRENERGIC RECEPTOR AGONIST THERAPY
    Publication number: 20190117623
    Abstract: Presented herein, inter alia, are novel methods of treating heart diseases.
    Type: Application
    Filed: February 24, 2017
    Publication date: April 25, 2019
    Inventors: Paul C. Simpson, Jr., Brian C. Jensen
  • Alpha-1-adrenergic receptor agonist therapy
    Patent number: 9364462
    Abstract: Presented herein inter alia are novel methods of treating heart and brain diseases.
    Type: Grant
    Filed: October 30, 2013
    Date of Patent: June 14, 2016
    Assignee: The Regents of the University of California
    Inventor: Paul C. Simpson, Jr.
  • Method of treatment using ?-1-adrenergic agonist compounds
    Patent number: 8778897
    Abstract: Methods for treating or preventing cardiomyopathy in a subject by administering an ?1 adrenergic receptor agonist, wherein the treatment does not result in increased blood pressure are provided.
    Type: Grant
    Filed: September 7, 2012
    Date of Patent: July 15, 2014
    Assignee: The Regents of the University of California
    Inventor: Paul C. Simpson, Jr.
  • ALPHA-1-ADRENERGIC RECEPTOR AGONIST THERAPY
    Publication number: 20140121257
    Abstract: Presented herein inter alia are novel methods of treating heart and brain diseases.
    Type: Application
    Filed: October 30, 2013
    Publication date: May 1, 2014
    Applicant: The Regents of the University of California
    Inventor: Paul C. Simpson, JR.
  • METHOD OF TREATMENT USING ALPHA-1-ADRENERGIC AGONIST COMPOUNDS
    Publication number: 20130040904
    Abstract: Methods for treating or preventing cardiomyopathy in a subject by administering an ?1 adrenergic receptor agonist, wherein the treatment does not result in increased blood pressure are provided.
    Type: Application
    Filed: September 7, 2012
    Publication date: February 14, 2013
    Applicant: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    Inventor: Paul C. Simpson
  • Method of treatment using alpha-1-adrenergic agonist compounds
    Patent number: 8324178
    Abstract: Methods for treating or preventing cardiomyopathy in a subject by administering an ?1 adrenergic receptor agonist, wherein the treatment does not result in increased blood pressure are provided.
    Type: Grant
    Filed: November 2, 2009
    Date of Patent: December 4, 2012
    Assignee: The Regents of the University of California
    Inventor: Paul C. Simpson, Jr.
  • Method of Treatment Using Alpha-1-Adrenergic Agonist Compounds
    Publication number: 20100113377
    Abstract: Methods for treating or preventing cardiomyopathy in a subject by administering an al adrenergic receptor agonist, wherein the treatment does not result in increased blood pressure are provided.
    Type: Application
    Filed: November 2, 2009
    Publication date: May 6, 2010
    Inventor: Paul C. Simpson